$ABBV Recent News Paulson takes stake in Abbvie, adds

New Post Public Reply Private Reply Replies (0) Message Board

Nov 30, 2014 at 4:13 PM

$ABBV Recent News

Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Obama considering Lazard banker for Treasury post 4:20 p.m. Nov. 12, 2014 - Victoria McGrane
77 stocks in the S&P 500 Index rise to new highs 10:50 a.m. Nov. 12, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
S&P 500, Dow close at record levels 4:16 p.m. Oct. 31, 2014 - Barbara Kollmeyer
Apple rallies to record high; LinkedIn jumps 11:05 a.m. Oct. 31, 2014 - Sue Chang
AbbVie stock up 3.6% at $63.38 9:32 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie shares up 4% in premarket trade 8:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie raises outlook as profit, sales beat 8:26 a.m. Oct. 31, 2014 - MarketWatch.com
AbbVie shares up 2% as profit, sales beat estimates 8:00 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie prior FY EPS outlook was $3.06 to $3.16 7:54 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie's stock gains 2.2% premarket after Q3 results beat expectations 7:53 a.m. Oct. 31, 2014 - Tomi Kilgore
AbbVie raises FY EPS outlook to $3.25 to $3.27 7:53 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 FactSet revenue consensus $4.831 bln 7:53 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 FactSet EPS consensus 77 cents 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 revenue $5.019 bln, up 7.85 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 adj. EPS 89 cents 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 EPS 31 cents vs 60 cents 7:51 a.m. Oct. 31, 2014 - Ciara Linnane
Mylan 3Q profit soars as revenue tops estimates 5:19 p.m. Oct. 30, 2014 - MarketWatch.com
12 highest-yielding ‘dividend aristocrat’ stocks 10:38 a.m. Oct. 30, 2014 - Philip van Doorn

Retirement Portfolio For Dummies - The Health Care Components 1:42 p.m. Today - Seeking Alpha
5 Stock-Moving Medtech Events This December 1:18 p.m. Nov. 28, 2014 - Investors Business Daily
Wall Street Breakfast: Crude Continues Decline Following OPEC Decision 6:32 a.m. Nov. 28, 2014 - Seeking Alpha
Bristol-Myers Squibb's HCV Drug Daclatasvir Receives CRL - Analyst Blog 1:00 p.m. Nov. 27, 2014 - Zacks.com
Dividend Aristocrats In Focus Part 45: AbbVie 12:57 p.m. Nov. 26, 2014 - Seeking Alpha
Novartis' Multiple Myeloma Drug FDA Action Date Delayed - Analyst Blog 12:55 p.m. Nov. 26, 2014 - Zacks.com
FDA Seeks More Data on Bristol-Myers Hepatitis C Therapy 12:17 p.m. Nov. 26, 2014 - The Wall Street Journal Interactive Edition
Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval - Analyst Blog 10:54 a.m. Nov. 26, 2014 - Zacks.com
6 High-Yielding Mega-Cap Stocks 9:53 a.m. Nov. 26, 2014 - Seeking Alpha
December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey 6:00 a.m. Nov. 26, 2014 - TheStreet.com
5 Stocks to Watch Closely for the Rest of 2014 2:38 a.m. Nov. 26, 2014 - InvestorPlace.com
Six High-Yielding Mega-Cap Stocks 4:22 p.m. Nov. 25, 2014 - GuruFocus.com
What did the billionaires do in Q3? 2:46 p.m. Nov. 25, 2014 - Seeking Alpha
Drug makers face pushback on pricey meds 8:18 a.m. Nov. 25, 2014 - Seeking Alpha
Be Careful With Gilead - It May Be Time To Take Profits 7:10 a.m. Nov. 25, 2014 - Seeking Alpha
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2014 Update 3:06 a.m. Nov. 25, 2014 - Seeking Alpha
AbbVie's HCV Cocktail Treatment Closer to EU Approval - Analyst Blog 7:00 p.m. Nov. 24, 2014 - Zacks.com
Novo Nordisk's Victoza Recommended for Label Expansion - Analyst Blog 6:15 p.m. Nov. 24, 2014 - Zacks.com
Can Partnering To Fight Hepatitis C Pay At Enanta? 3:44 p.m. Nov. 24, 2014 - Investors Business Daily
Dividend Aristocrats In Focus Part 45: AbbVie 3:13 p.m. Nov. 24, 2014 - GuruFocus.com

Gardy & Notis LLP Issues Notice Of The Filing Of A Securities Class Action Against AbbVie And Its Chief Executive Officer 4:00 p.m. Nov. 26, 2014 - PR Newswire - PRF
CHMP Grants Positive Opinions of AbbVie's VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe 8:00 a.m. Nov. 21, 2014 - PR Newswire - PRF
AbbVie to Present at Jefferies 2014 Global Healthcare Conference 7:00 a.m. Nov. 17, 2014 - PR Newswire - PRF
AbbVie Presents Results from Study of ABT-414 in Patients with Glioblastoma Multiforme at the 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology 4:48 p.m. Nov. 14, 2014 - PR Newswire - PRF
AbbVie to Present Results from Studies in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) and Liver Transplant Recipients (CORAL-I) at The Liver Meeting® 2014 9:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
AbbVie to Present Results from Phase 2 PEARL-I Study in Genotype 4 Chronic Hepatitis C Patients at The Liver Meeting® 2014 8:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Infinity Reports Third Quarter 2014 Financial Results and Provides Company Update 4:01 p.m. Nov. 6, 2014 - BusinessWire - BZX
Technical Notes Covering Pharma Equities - AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, and Teva Pharma Industries 8:50 a.m. Nov. 6, 2014 - PR Newswire - PRF
ABBVIE (ABBV) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating AbbVie Inc. For Potential Securities Fraud and Breach of Fiduciary Duty 8:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
AbbVie to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
ABBVIE INC. ALERT -- Andrews & Springer LLC is Investigating AbbVie Inc. for Potential Securities Fraud and Breach of Fiduciary Duty 8:09 a.m. Nov. 3, 2014 - GlobeNewswire
Myriad and AbbVie Sign Expanded Agreement for Tumor BRACAnalysis CDx(TM) 7:05 a.m. Nov. 3, 2014 - GlobeNewswire
CMK Select Recognized as Women's Business Enterprise 10:45 a.m. Oct. 31, 2014 - Marketwired
AbbVie Reports Third-Quarter 2014 Financial Results 7:49 a.m. Oct. 31, 2014 - PR Newswire - PRF
If You Purchased Shire plc American Depository Receipts ("ADRs"

During The Period Of June 20, 2014 And October 14, 2014 And Lost Money, Gardy & Notis, LLP Encourages You To Contact The Law Firm 8:38 a.m. Oct. 29, 2014 - PR Newswire - PRF
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly 8:35 a.m. Oct. 29, 2014 - PR Newswire - PRF
AbbVie Named a Top Employer in Science Magazine's Annual Survey for Second Consecutive Year 8:00 a.m. Oct. 23, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
AbbVie Announces New $5 Billion Stock Repurchase Program and Increases Dividend 5:31 p.m. Oct. 20, 2014 - PR Newswire - PRF
Announcement Of Termination Of Proposed AbbVie And Shire Transaction 5:12 p.m. Oct. 20, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LifeSecure Expands with Starscape Agency Launch

LifeSecure's Strategic Move into the Insurance Space LifeSecure Holdings Corporation is planting new roots with its latest venture, Starscape Insurance Agency. This ain't just another splash in the kiddie pool, buddy. This is a big step in bolstering its standing in the insurance sector, focusing sharply on health insurance solutions for individuals, families, and even...

HSG's Laser Tech Dazzles at FABTECH 2026

By Caleb Price Updated Oct 23, 2026 Category News Views 10

Laser Innovations on Display at FABTECH 2026 Listen up, folks—FABTECH 2026 in Vegas is where HSG Laser decided to flaunt their new toys, codenamed TS2 PRO and the mystical AI CutPilot. Now, unless you've been living under a rock, you'll know HSG is all about shaking up the laser cutting scene. They've done it for two decades, and now they're pushing the envelope with...

HumanView Relaunch: LEAP Group Decodes Customer Signals

Understanding Customer Signals Like Never Before Well, here's one for the ol' playbook. The LEAP Group just dusted off their tool, HumanView, like an old car getting a fresh coat of paint and an engine overhaul. It's been rebuilt from the ground up, promising to turn those random blips of online chatter into actionable business insights. Not the same old dashboard mumbo...

Symplr's Strategic Refinancing: A Shot in the Arm

Symplr's Financial Revamp: What It Means You're not often floored by a refinancing move, but symplr's announcement on October 23 sure seems like a savvy maneuver. For a company that's already a lynchpin in healthcare operations, extending debt maturities and juicing up liquidity is like an adrenaline shot to the ticker. And for me, it's the confidence from heavyweights...

Italian Excellence: NYC Celebrates Innovators and Icons

The Fusion of Italian Artistry and Innovation Imagine blending business savvy with a touch of culture and ethics. That's the spirit of the 9th Business Care International Award, which is gearing up to hit New York City's grand stage come November 18-19. This ain't just about pats on the back; it's a recognition of those who push Italian excellence across oceans and into...

Abbott's Oncodetect Test: Game-Changer for Cancer Recurrence

Pioneering Progress in Colorectal Cancer Detection There's a new player in the world of cancer diagnostics, and it's setting a fresh standard. Abbott's Oncodetect test, featured at the ESMO Congress, has shown a profound leap in sensitivity—30 percent over the older whole-exome sequencing approach. For those doing the math on the stock charts, Abbott (NYSE: ABT) is...

Paolo Moretti: New CEO Steering RINA's Dynamic Course

Leadership Shift in the Heart of RINA Today's news is a hefty dose of strategic sea change over at RINA S.p.A., where Paolo Moretti's been handed the reins as the new Group Chief Executive Officer. Now, if you haven't been following, RINA's been riding a serious wave—revenues have more than doubled in a neat five-year streak, claiming over a billion euros. So, what we...

FP Movement Opens Energizing Boutique in Cranston, RI

FP Movement Expands with Style in Rhode Island FP Movement is shaking things up in Cranston, Rhode Island, bringing its signature activewear vibe to Garden City Center with a new shop. It’s not just about buying leggings anymore; it’s about diving into a lifestyle that screams energy and community spirit. The store, which spans 1,209 selling-square-feet, opened its...

TLC Jet Teams Up with WIMCO St. Barth Properties

Setting the Jet Set Stage Aflame In the ever-glam world of high-end travel, TLC Jet, out of Fort Lauderdale, has just inked a deal with WIMCO St. Barth Properties. Look, if you've got a penchant for island hopping or sipping your cocktail with sand between your toes, this aligns perfectly with your luxury cravings. This duo isn't just whispering sweet nothings in the...

Gildan Activewear Faces 18.8% Hit Amid Securities Suit

Gildan's Channel Stuffing Allegations If July showers bring August flowers, then what do June allegations bring? A stock nosedive, if you’re Gildan Activewear. Investors woke up June 16, 2026, to a harrowing drop, with shares slipping nearly 19%. It's the kind of gut-punch that makes one wonder if summer vacation is over before it even starts. Jehoshaphat Research...